http://www.fpnotebook.com/
Atrial Fibrillation Rate Control
- See Also
- Guidelines 2000 CPR and Emergency Cardiovascular Care
- Atrial Fibrillation
- Atrial Fibrillation Acute Management
- Atrial Fibrillation Anticoagulation
- Atrial Fibrillation Cardioversion
- Indications
- Atrial Fibrillation with rapid ventricular rate
- Precautions
- Beware agents which may cardiovert Atrial Fib >48 hours
- Risk of embolic complications
- Target Heart Rate
- Heart Rate: 70-90 bpm
- Rate Control: WPW Syndrome with preserved heart function
- General
- Risk of embolus if rhythm cardioverts
- Consider Atrial Fibrillation Anticoagulation
- Avoid Harmful agents
- Adenosine
- Beta Blocker
- Calcium Channel Blocker
- Digoxin
- Recommended agents (Use only 1 agent)
- Electrical Synchronized Cardioversion if unstable
- Class IA Agents
- Procainamide
- Class IC Agents
- Propafenone (Rythmol)
- Flecainide (Tambocor)
- Class III Agents
- Amiodarone (Cordarone)
- Sotalol (Betapace)
- Rate control: WPW with Ejection Fraction <40%
- General
- Risk of embolus if rhythm cardioverts
- Consider Atrial Fibrillation Anticoagulation
- Recommended agents
- Electrical Synchronized Cardioversion
- Amiodarone (Cordarone)
- Rate control: Heart function preserved (No WPW)
- General
- Risk of embolus if rhythm cardioverts
- Consider Atrial Fibrillation Anticoagulation
- Recommended agents
- Beta Blockers
- Propranolol (Inderal)
- Esmolol (Brevibloc)
- Metoprolol (Lopressor)
- Calcium Channel Blocker
- Verapamil (Calan)
- Diltiazem (Cardizem) - preferred
- See Diltiazem for dosing protocol
- Rate control: Ejection Fraction <40% (No WPW)
- General
- Risk of embolus if rhythm cardioverts
- Consider Atrial Fibrillation Anticoagulation
- Recommended agents
- Digoxin (Lanoxin)
- Diltiazem (Cardizem) - preferred
- Amiodarone
- Choosing longterm rate versus rhythm control
- Rate control has less drug-related adverse effects
- Rate control has equivalent efficacy to rhythm control
- Same survival benefit
- Same Cerebrovascular Accident risk
- Rhythm control may offer benefit in age <65 years
- References
- Wyse (2002) N Engl J Med 347:1825
- References
- Dell'Orfano (1998) Am Fam Physician 58(2):471
- Hebbar (2002) Am Fam Physician 65(12):2479
- King (2002) Am Fam Physician 66:249
- (2000) Circulation, 102(Suppl I):86-9
- http://www.circulationaha.org
Navigation Tree